140 related articles for article (PubMed ID: 4187027)
21. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
Pattyn SR; Portaels F; Van Loo G; Van den Breen L
Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
[TBL] [Abstract][Full Text] [Related]
22. Detection of persisting Mycobacterium leprae by inoculation of the neonatally thymectomized rat.
Gelber RH; Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):872-8. PubMed ID: 3325581
[No Abstract] [Full Text] [Related]
23. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
24. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
25. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
26. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
Holmes IB
Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
[No Abstract] [Full Text] [Related]
27. The lack of effect of methimazole therapy in lepromatous leprosy. Reassessment by examination of bacterial morphology.
Levy L; Murray LP; Fasal P
Int J Lepr Other Mycobact Dis; 1967; 35(2):149-53. PubMed ID: 4165669
[No Abstract] [Full Text] [Related]
28. [New methods of experimental chemotherapy in leprosy].
Wagner WH
Hautarzt; 1969 Sep; 20(9):385-9. PubMed ID: 4191849
[No Abstract] [Full Text] [Related]
29. Mouse foot pad growth of M. leprae in relation to bacteriological index.
Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
[TBL] [Abstract][Full Text] [Related]
30. Primary dapsone resistant leprosy in Nepal.
Samuel NM; Samuel S; Loudon J; Adiga RB
Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343
[TBL] [Abstract][Full Text] [Related]
31. Primary dapsone-resistant leprosy in Cebu, Philippines.
Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
[TBL] [Abstract][Full Text] [Related]
32. Studies in the viability of Mycobacterium leprae in human liver and bone marrow using thymectomized mouse foot pad technic.
Karat AB; Harmer H; Kumar AS; Albert JR
Int J Lepr Other Mycobact Dis; 1972; 40(1):1-3. PubMed ID: 4562382
[No Abstract] [Full Text] [Related]
33. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
Almeida JG; Chacko CJ; Christian M
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
[TBL] [Abstract][Full Text] [Related]
34. Mouse foot-pad growth patterns of M. leprae in relation to morphological index.
Venkataramaniah HN; Harikrishnan S; Balakrishnan S; Bhatia VN
Lepr India; 1982 Oct; 54(4):634-8. PubMed ID: 6763966
[No Abstract] [Full Text] [Related]
35. The problem of dapsone-resistant leprosy.
Pearson JM
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
[No Abstract] [Full Text] [Related]
36. Dapsone-resistant leprosy-the THELEP approach.
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
[No Abstract] [Full Text] [Related]
37. Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad.
Rees RJ
Int J Lepr; 1965; 33(3):Suppl:646-57. PubMed ID: 5322707
[No Abstract] [Full Text] [Related]
38. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
39. Study of the involvement of the sciatic nerve following inoculation with M. leprae and other mycobacteria in the mouse foot pad.
Kamala AN; Antia NH; Shetty VP
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):506-14. PubMed ID: 6100185
[TBL] [Abstract][Full Text] [Related]
40. "Drug-resistant proportion test" for M. leprae to quantify the proportion of drug-resistant M. leprae in a sample using the mouse foot pad.
Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):468-70. PubMed ID: 6399066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
